News

Prestige BioPharma Ltd. announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its first-in-class anti-PAUF monoclonal antibody, PBP1510,…
Read More...

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer Inc. announced that the US Food and Drug Administration (FDA) has approved…
Read More...

Roche announced that the US Food and Drug Administration (FDA) has approved Phesgo, a fixed-dose combination of Perjeta (pertuzumab) and Herceptin (trastuzumab) with hyaluronidase,…
Read More...

Meissa Vaccines announced that the company has initiated preclinical studies and manufacturing and completed a pre-IND meeting with the U.S. Food and Drug Administration (FDA) for the…
Read More...

Carmine Therapeutics announced that it has signed a research collaboration agreement with Takeda Pharmaceutical Company Limited to discover, develop and commercialize transformative…
Read More...

Sinclair Research announced completion of successful validation of GLP ototoxicity testing services in partnership with Turner Scientific, an industry leader specializing in nonclinical…
Read More...

Merck, known as MSD outside the United States and Canada, announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA, Merck’s anti-PD-1 therapy, as monotherapy for…
Read More...

VITRAC Therapeutics, LLC (VITRAC) initiated the global clinical development of VIC-1911, an oncology candidate formally known as TAS-119, which was licensed from Taiho Pharmaceutical…
Read More...

Biocare Medical announces a collaborative partnership with Bethyl Laboratories to develop targeted antibodies for cancer research and oncology diagnostics. Bethyl Laboratories has 45…
Read More...

SFA Therapeutics, Inc. announced that the US FDA has provided approval to conduct a clinical trial (officially referred to as an IND) for the treatment of "the appearance of the…
Read More...

Nordic Nanovector ASA announces that the US Food and Drug Administration (FDA) has granted Fast Track designation for investigating Betalutin (177Lu lilotomab satetraxetan) for the…
Read More...

GlaxoSmithKline plc announced the approval of a Japanese New Drug Application (JNDA) by the Ministry of Health, Labour and Welfare for Duvroq (daprodustat) tablets, an oral…
Read More...

Tiziana Life Sciences plc announces the execution of an agreement with STC Biologics, Inc. for GMP manufacturing of TZLS-501, an anti-IL-6 receptor (anti-IL-6R) monoclonal antibody…
Read More...

Novartis Pharma K.K. announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved Tabrecta (capmatinib, formerly INC280), an oral MET inhibitor for MET exon 14…
Read More...

LabCorp announced the launch of a new test that can be used to assess the capacity of antibodies in patient plasma to inhibit the SARS-CoV-2 virus. This information could be used in the…
Read More...

Allergan, an AbbVie Company and Molecular Partners, a clinical-stage biotechnology company developing a new class of custom-built protein therapeutics known as DARPin therapeutics,…
Read More...

Moderna, Inc. and Catalent, Inc. announced a collaboration for large-scale, commercial fill-finish manufacturing of Moderna’s mRNA-based COVID-19 vaccine candidate (mRNA-1273) at…
Read More...

Aldevron announced an agreement with Ziopharm Oncology to produce plasmid DNA for T cell therapy of solid tumors. Aldevron has developed the neoGMP service level designed to address…
Read More...

PPD, Inc. has expanded its laboratory test portfolio by adding five new molecular, serology and functional assays designed expressly for COVID-19 vaccine and therapy development…
Read More...

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, announced the U.S. Food and Drug Administration (FDA) has cleared its investigational…
Read More...